cytarabine has been researched along with Diabetes Mellitus in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Boudreault, JS; Desjardins, A; Feng, X; Le-Nguyen, V; Rioux, JP; Turgeon-Mallette, L; Veilleux, A; Vo, C | 1 |
Amrein, PC; Attar, EC; Ballen, KK; Brunner, AM; Chen, YB; Drapkin, BJ; Fathi, AT; Feng, Y; McAfee, SL; Neuberg, DS; Sadrzadeh, H | 1 |
Armitage, JO; Maragos, D; Schouten, HC; Vose, J | 1 |
Liu, PL | 1 |
1 trial(s) available for cytarabine and Diabetes Mellitus
Article | Year |
---|---|
Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemia.
Topics: Age Factors; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Body Mass Index; Coronary Artery Disease; Cytarabine; Diabetes Mellitus; Disease-Free Survival; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Retrospective Studies; Risk Factors; Survival Rate | 2013 |
3 other study(ies) available for cytarabine and Diabetes Mellitus
Article | Year |
---|---|
Bendamustine-induced nephrogenic diabetes insipidus - A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cytarabine; Diabetes Insipidus, Nephrogenic; Diabetes Mellitus; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Transplantation, Autologous | 2022 |
Diabetes mellitus or an impaired glucose tolerance as a potential complicating factor in patients treated with high-dose therapy and autologous bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Diabetes Mellitus; Dose-Response Relationship, Drug; Etoposide; Female; Glucose; Graft Rejection; Heart; Hodgkin Disease; Humans; Kidney; Liver; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies | 1990 |
[Care of patients with leukemia complicated by diabetes mellitus during chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diabetes Mellitus; Female; Harringtonines; Humans; Leukemia; Male; Prednisone; Vincristine | 1987 |